JAGUAR HEALTH, INC. Income Taxes Paid
JAGUAR HEALTH, INC. (JAGX) reported Income Taxes Paid of $19.34 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2019-08-14
- JAGUAR HEALTH, INC. income taxes paid, net for the quarter ending 2018-06-30 was $0.00.
- JAGUAR HEALTH, INC. income taxes paid, net for the quarter ending 2018-03-31 was $19.34K.
- JAGUAR HEALTH, INC. income taxes paid, net for the quarter ending 2017-12-31 was $32.72K, a 65.87% decline year-over-year.
- JAGUAR HEALTH, INC. income taxes paid, net for the quarter ending 2016-12-31 was $95.86K.
- JAGUAR HEALTH, INC. income taxes paid, net for fiscal 2018 was $19.34K, a 91.75% decline from fiscal 2017.
- JAGUAR HEALTH, INC. income taxes paid, net for fiscal 2017 was $234.55K, a 51.00% decline from fiscal 2016.
- JAGUAR HEALTH, INC. income taxes paid, net for fiscal 2016 was $478.67K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2018-12-31 | $19.34K 10-K · filed 2019-04-10 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $19.34K 10-Q · filed 2019-08-14 | $52.06K derived: sum of 3 quarters · filed 2019-08-14 | |
| 2018-03-31 | $19.34K 10-Q · filed 2019-05-21 | $52.06K derived: sum of 2 quarters · filed 2019-05-21 | ||
| 2017-12-31 | $32.72K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $234.55K 10-K · filed 2019-04-10 | ||
| 2017-09-30 | $201.84K 10-Q · filed 2017-11-20 | |||
| 2016-12-31 | $95.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $478.67K 10-K · filed 2018-04-09 | ||
| 2016-09-30 | $382.81K 10-Q · filed 2017-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |